...
首页> 外文期刊>Integrative Biology >Improving the classification of brain tumors in mice with perturbation enhanced (PE)-MRSI
【24h】

Improving the classification of brain tumors in mice with perturbation enhanced (PE)-MRSI

机译:增强摄动(PE)-MRSI改善小鼠脑肿瘤的分类

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Classifiers based on statistical pattern recognition analysis of MRSI data are becoming important tools for the non-invasive diagnosis of human brain tumors. Here we investigate the potential interest of perturbation-enhanced MRSI (PE-MRSI), in this case acute hyperglycemia, for improving the discrimination between mouse brain MRS patterns of glioblastoma multiforme (GBM), oligodendroglioma (ODG), and non-tumor brain parenchyma (NT). Six GBM-bearing mice and three ODG-bearing mice were scanned at 7 Tesla by PRESS-MRSI with 12 and 136 ms echo-time, during euglycemia (Eug) and also during induced acute hyperglycemia (Hyp), generating altogether four datasets per animal (echo time + glycemic condition): 12Eug, 136Eug, 12Hyp, and 136Hyp. For classifier development all spectral vectors (spv) selected from the MRSI matrix were unit length normalized (UL2) and used either as a training set (76 GBM spv, four mice; 70 ODG spv, two mice; 54 NT spv) or as an independent testing set (61 GBM spv, two mice; 31 ODG, one mouse; 23 NT spv). All Fisher's LDA classifiers obtained were evaluated as far as their descriptive performance—correctly classified cases of the training set (bootstrapping)—and predictive accuracy—balanced error rate of independent testing set classification. MRSI-based classifiers at 12Hyp were consistently more efficient in separating GBM, ODG, and NT regions, with overall accuracies always >80% and up to 95–96%; remaining classifiers were within the 48–85% range. This was also confirmed by user-independent selection of training and testing sets, using leave-one-out (LOO). This highlights the potential interest of perturbation-enhanced MRSI protocols for improving the non-invasive characterization of preclinical brain tumors.
机译:基于对MRSI数据的统计模式识别分析的分类器正成为非侵入性诊断人脑肿瘤的重要工具。在这里,我们研究了扰动增强型MRSI(PE-MRSI)(在这种情况下为急性高血糖症)对于改善多形性胶质母细胞瘤(GBM),少突胶质细胞瘤(ODG)和非肿瘤性脑实质的小鼠脑MRS模式之间的区别的潜在兴趣(NT)。在正常血糖(Eug)期间和诱发的急性高血糖(Hyp)期间,通过PRESS-MRSI在12和136 ms的回波时间在7 Tesla下扫描了6只有GBM的小鼠和3只ODG的小鼠,每只动物共生成了四个数据集(回波时间+血糖状况):12Eug,136Eug,12Hyp和136Hyp。为了进行分类器开发,将从MRSI矩阵中选择的所有频谱向量(spv)进行单位长度归一化(UL2),并用作训练集(76 GBM spv,四只小鼠; 70 ODG spv,两只小鼠; 54 NT spv)或用作独立测试集(61 GBM spv,两只小鼠; 31 ODG,一只小鼠; 23 NT spv)。评估所有获得的Fisher的LDA分类器的描述性能-正确分类的训练集(自举)情况和预测准确性-独立测试集分类的错误率。在12Hyp上基于MRSI的分类器在分离GBM,ODG和NT区域方面一直效率更高,总精度始终> 80%,最高可达95-96%。其余的分类器在48-85%的范围内。使用留一法(LOO),用户独立选择培训和测试集也证实了这一点。这凸显了扰动增强型MRSI协议对改善临床前脑肿瘤的非侵入性表征的潜在兴趣。

著录项

  • 来源
    《Integrative Biology》 |2012年第2期|p.183-191|共9页
  • 作者单位

    1. Bioquímica i Biologia Molecular,Facultat de Biociències,Universitat Autònoma de Barcelona, , Spain@@2. Centro de Investigación Biomédica en Red – Bioingeniería,Biomateriales y Nanomedicina (CIBER-BBN), , Spain;

    1. Bioquímica i Biologia Molecular,Facultat de Biociències,Universitat Autònoma de Barcelona, , Spain@@2. Centro de Investigación Biomédica en Red – Bioingeniería,Biomateriales y Nanomedicina (CIBER-BBN), , Spain@@3. Institut de Biotecnologia i de Biomedicina,Universitat Autònoma de Barcelona, , Spain;

    1. Bioquímica i Biologia Molecular,Facultat de Biociències,Universitat Autònoma de Barcelona, , Spain@@2. Centro de Investigación Biomédica en Red – Bioingeniería,Biomateriales y Nanomedicina (CIBER-BBN), , Spain;

    1. Centre de Résonance Magnétique Biologique et Médicale (CRMBM), UMR CNRS 6612, Marseille, France;

    1. Murine Pathology Unit,Centre de Biotecnologia Animal i Teràpia Gènica,Departament de Medicina i Cirurgia Animals,Universitat Autònoma de Barcelona, , Spain;

    1. Centro de Investigación Biomédica en Red – Bioingeniería,Biomateriales y Nanomedicina (CIBER-BBN), , Spain@@2. Bioquímica i Biologia Molecular,Facultat de Biociències,Universitat Autònoma de Barcelona, , Spain;

    1. Bioquímica i Biologia Molecular,Facultat de Biociències,Universitat Autònoma de Barcelona, , Spain@@2. Centro de Investigación Biomédica en Red – Bioingeniería,Biomateriales y Nanomedicina (CIBER-BBN), , Spain;

    1. Department of Radiation Oncology,Miller School of Medicine,University of Miami, , USA;

    1. Centre de Résonance Magnétique Biologique et Médicale (CRMBM), UMR CNRS 6612, Marseille, France;

    1. Centro de Investigación Biomédica en Red – Bioingeniería,Biomateriales y Nanomedicina (CIBER-BBN), , Spain@@2. Bioquímica i Biologia Molecular,Facultat de Biociències,Universitat Autònoma de Barcelona, , Spain@@3. Institut de Biotecnologia i de Biomedicina,Universitat Autònoma de Barcelona, , Spain;

    1. Bioquímica i Biologia Molecular,Facultat de Biociències,Universitat Autònoma de Barcelona, , Spain@@2. Centro de Investigación Biomédica en Red – Bioingeniería,Biomateriales y Nanomedicina (CIBER-BBN), , Spain@@3. Institut de Biotecnologia i de Biomedicina,Universitat Autònoma de Barcelona, , Spain;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号